A pharmaceutical company supplying rapid antigen tests to Coles and Woolworths has rejected allegations it did not provide up-to-date safety and efficacy data and adequate support to consumers.
On Wednesday the Therapeutic Goods Administration (TGA) fined Hough Pharma $106,560 for “serial non-compliance” with regulatory requirements. All manufactures of therapeutic goods, including tests, drugs and medical devices approved for use in Australia, must continually provide safety and performance data to the TGA as requested.
